COST IMPLICATIONS OF ADAPTING THE INVESTIGATION AND DIAGNOSIS PATHWAY OF INFERTILTY PATIENTS IN A UK NHS SETTING

Author(s)

Davies S¹, Umranikar A¹, Huggins T², Gauthier A³, Harty GT²
¹Salisbury NHS Foundation Trust, Salisbury, UK, ²Merck Serono, London, UK, ³Amaris, London, UK

Presentation Documents

PHS121--strong-u-davies-s-u-sup-1-sup-strong-umranikar-a-sup-1-sup-huggins-t-sup-2-sup-gauthier-a-sup-3-sup-harty-gt-sup-2-sup-br-sup-1-sup-salisbury-nhs-foundation-trust-salisbury-uk-sup-2-sup-merck-serono-london-uk-sup-3-sup-amaris-london ...

OBJECTIVES:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PHS121

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis

Disease

Reproductive and Sexual Health

Explore Related HEOR by Topic

Economic Evaluation

Presentation